Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1702473

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1702473

Population Health Management Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

PUBLISHED:
PAGES: 320 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The global population health management (PHM) market is expected to grow significantly, projected to increase from USD 32.7 billion in 2024 to USD 91.0 billion by 2032, expanding at a compound annual growth rate (CAGR) of 13.8%. This growth is being driven by several key factors, including the transition from traditional fee-for-service models to value-based care, an increased focus on managing chronic diseases, and the rising adoption of healthcare IT solutions. The population health management market plays a crucial role in improving healthcare outcomes, reducing costs, and enhancing the efficiency of care delivery by using data-driven approaches to manage the health of large patient populations.

PHM solutions enable healthcare providers to optimize care and better manage patient populations by integrating clinical, financial, and operational data. These solutions focus on improving care coordination, reducing hospital readmissions, enhancing patient engagement, and addressing the growing prevalence of chronic diseases. By adopting these solutions, healthcare providers are able to shift from reactive to proactive care, ultimately improving outcomes and reducing unnecessary healthcare costs. The market is seeing a strong push toward value-based care, where healthcare providers are incentivized to improve patient health while controlling costs, making PHM solutions an essential tool in modern healthcare systems.

Key Insights

One of the primary drivers of the PHM market is the growing prevalence of chronic diseases. Chronic conditions such as cardiovascular diseases, diabetes, and cancer place a significant burden on healthcare systems globally. According to the World Health Organization (WHO), chronic diseases are responsible for the majority of deaths worldwide, highlighting the need for effective management solutions. PHM systems allow for better tracking and management of these conditions by utilizing data analytics to optimize care delivery, identify at-risk populations, and intervene before conditions worsen. This results in fewer hospital admissions, improved health outcomes, and reduced treatment costs.

Another key driver for the market is the increasing demand for personalized medicine and precision healthcare. As healthcare providers increasingly focus on individualized care plans, PHM systems offer insights into patients' health conditions, allowing for more accurate treatment options. Personalized healthcare not only improves outcomes but also reduces unnecessary healthcare expenditures, contributing to the growing demand for PHM solutions. The shift towards personalized care is particularly relevant for conditions like cancer, diabetes, and genetic disorders, where tailored treatment plans can significantly improve patient prognosis.

In addition to the demand for chronic disease management and personalized care, the adoption of healthcare IT solutions is also accelerating the growth of the PHM market. Cloud-based PHM solutions are expected to see the highest growth rate due to their scalability, flexibility, and cost-effectiveness. Cloud solutions allow healthcare providers to access patient data from anywhere, collaborate with other healthcare professionals, and store large amounts of data without the need for significant on-site infrastructure investments. As healthcare organizations move toward more integrated, data-driven systems, cloud-based PHM platforms will be a key component in streamlining care coordination and improving operational efficiency.

The software segment dominates the market, contributing significantly to the growth of PHM. PHM software systems facilitate better care coordination, reduce hospital readmissions, and enhance overall operational efficiency. These solutions are crucial in managing patient populations by offering predictive analytics and insights that support decision-making and improve care quality. As healthcare providers continue to shift toward value-based care models, the role of software in supporting these initiatives becomes increasingly important.

Despite its promising growth, the PHM market faces challenges, including high infrastructure costs and the shortage of skilled professionals, particularly in underdeveloped regions. These barriers could slow the adoption of PHM solutions, particularly in low- and middle-income countries where healthcare systems may struggle to implement these advanced technologies.

Product Code: 10242

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by delivery mode
    • 1.4.2. Market size breakdown, by component
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Delivery Mode (2019-2030)
  • 6.3. Market Revenue, by Component (2019-2030)
  • 6.4. Market Revenue, by End User (2019-2030)
  • 6.5. Market Revenue, by Region (2019-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Delivery Mode (2019-2030)
  • 7.3. Market Revenue, by Component (2019-2030)
  • 7.4. Market Revenue, by End User (2019-2030)
  • 7.5. Market Revenue, by Country (2019-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Delivery Mode (2019-2030)
  • 8.3. Market Revenue, by Component (2019-2030)
  • 8.4. Market Revenue, by End User (2019-2030)
  • 8.5. Market Revenue, by Country (2019-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Delivery Mode (2019-2030)
  • 9.3. Market Revenue, by Component (2019-2030)
  • 9.4. Market Revenue, by End User (2019-2030)
  • 9.5. Market Revenue, by Country (2019-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Delivery Mode (2019-2030)
  • 10.3. Market Revenue, by Component (2019-2030)
  • 10.4. Market Revenue, by End User (2019-2030)
  • 10.5. Market Revenue, by Country (2019-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Delivery Mode (2019-2030)
  • 11.3. Market Revenue, by Component (2019-2030)
  • 11.4. Market Revenue, by End User (2019-2030)
  • 11.5. Market Revenue, by Country (2019-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Delivery Mode (2019-2030)
  • 12.3. Market Revenue, by Component (2019-2030)
  • 12.4. Market Revenue, by End User (2019-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Delivery Mode (2019-2030)
  • 13.3. Market Revenue, by Component (2019-2030)
  • 13.4. Market Revenue, by End User (2019-2030)
  • 13.5. Germany Market
  • 13.6. Overview
  • 13.7. Market Revenue, by Delivery Mode (2019-2030)
  • 13.8. Market Revenue, by Component (2019-2030)
  • 13.9. Market Revenue, by End User (2019-2030)

Chapter 14. France Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Delivery Mode (2019-2030)
  • 14.3. Market Revenue, by Component (2019-2030)
  • 14.4. Market Revenue, by End User (2019-2030)

Chapter 15. U.K. Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Delivery Mode (2019-2030)
  • 15.3. Market Revenue, by Component (2019-2030)
  • 15.4. Market Revenue, by End User (2019-2030)

Chapter 16. Italy Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Delivery Mode (2019-2030)
  • 16.3. Market Revenue, by Component (2019-2030)
  • 16.4. Market Revenue, by End User (2019-2030)

Chapter 17. Spain Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Delivery Mode (2019-2030)
  • 17.3. Market Revenue, by Component (2019-2030)
  • 17.4. Market Revenue, by End User (2019-2030)

Chapter 18. Japan Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Delivery Mode (2019-2030)
  • 18.3. Market Revenue, by Component (2019-2030)
  • 18.4. Market Revenue, by End User (2019-2030)

Chapter 19. China Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Delivery Mode (2019-2030)
  • 19.3. Market Revenue, by Component (2019-2030)
  • 19.4. Market Revenue, by End User (2019-2030)

Chapter 20. India Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Delivery Mode (2019-2030)
  • 20.3. Market Revenue, by Component (2019-2030)
  • 20.4. Market Revenue, by End User (2019-2030)

Chapter 21. Australia Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Delivery Mode (2019-2030)
  • 21.3. Market Revenue, by Component (2019-2030)
  • 21.4. Market Revenue, by End User (2019-2030)

Chapter 22. South Korea Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Delivery Mode (2019-2030)
  • 22.3. Market Revenue, by Component (2019-2030)
  • 22.4. Market Revenue, by End User (2019-2030)

Chapter 23. Brazil Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Delivery Mode (2019-2030)
  • 23.3. Market Revenue, by Component (2019-2030)
  • 23.4. Market Revenue, by End User (2019-2030)

Chapter 24. Mexico Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Delivery Mode (2019-2030)
  • 24.3. Market Revenue, by Component (2019-2030)
  • 24.4. Market Revenue, by End User (2019-2030)

Chapter 25. Saudi Arabia Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Delivery Mode (2019-2030)
  • 25.3. Market Revenue, by Component (2019-2030)
  • 25.4. Market Revenue, by End User (2019-2030)

Chapter 26. South Africa Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Delivery Mode (2019-2030)
  • 26.3. Market Revenue, by Component (2019-2030)
  • 26.4. Market Revenue, by End User (2019-2030)

Chapter 27. U.A.E. Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Delivery Mode (2019-2030)
  • 27.3. Market Revenue, by Component (2019-2030)
  • 27.4. Market Revenue, by End User (2019-2030)

Chapter 28. Competitive Landscape

  • 28.1. List of Market Players and their Offerings
  • 28.2. Competitive Benchmarking of Key Players
  • 28.3. Product Benchmarking of Key Players
  • 28.4. Recent Strategic Developments

Chapter 29. Company Profiles

  • 29.1. McKesson Corporation
    • 29.1.1. Business overview
    • 29.1.2. Product and service offerings
    • 29.1.3. Key financial summary
  • 29.2. Cerner Corporation
    • 29.2.1. Business overview
    • 29.2.2. Product and service offerings
    • 29.2.3. Key financial summary
  • 29.3. Wellcentive Inc.
    • 29.3.1. Business overview
    • 29.3.2. Product and service offerings
    • 29.3.3. Key financial summary
  • 29.4. Allscript Healthcare Solutions Inc.
    • 29.4.1. Business overview
    • 29.4.2. Product and service offerings
    • 29.4.3. Key financial summary
  • 29.5. IBM Corporation
    • 29.5.1. Business overview
    • 29.5.2. Product and service offerings
    • 29.5.3. Key financial summary
  • 29.6. Optum Inc.
    • 29.6.1. Business overview
    • 29.6.2. Product and service offerings
    • 29.6.3. Key financial summary
  • 29.7. Health Catalyst
    • 29.7.1. Business overview
    • 29.7.2. Product and service offerings
    • 29.7.3. Key financial summary
  • 29.8. Conifer Health Solutions LLC
    • 29.8.1. Business overview
    • 29.8.2. Product and service offerings
    • 29.8.3. Key financial summary
  • 29.9. Koninklijke Philips N.V.
    • 29.9.1. Business overview
    • 29.9.2. Product and service offerings
    • 29.9.3. Key financial summary
  • 29.10. Epic Systems Corporation
    • 29.10.1. Business overview
    • 29.10.2. Product and service offerings
    • 29.10.3. Key financial summary

Chapter 30. Appendix

  • 30.1. Abbreviations
  • 30.2. Sources and References
  • 30.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!